Skip to Main content
Number of documents


Amandine Etcheverry

Journal articles25 documents

  • Anan Yin, Zhende Shang, Amandine Etcheverry, Yalong He, Marc Aubry, et al.. Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas. OncoImmunology, Taylor & Francis, 2021, 10 (1), ⟨10.1080/2162402X.2021.1902071⟩. ⟨hal-03206742⟩
  • Pierre Jean Le Reste, R Pineau, Konstantinos Voutetakis, J Samal, Gwenaele Jegou, et al.. Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo. Cancer Letters, Elsevier, 2020, 494, pp.73-83. ⟨10.1016/j.canlet.2020.08.028⟩. ⟨hal-02959985⟩
  • Camille Lachat, Diane Bruyère, Amandine Etcheverry, Marc Aubry, Jean Mosser, et al.. EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas. Cancers, MDPI, 2020, 12 (12), ⟨10.3390/cancers12123649⟩. ⟨hal-03099270⟩
  • Mathilde Cheray, Amandine Etcheverry, Camille Jacques, Romain Pacaud, Gwenola Bougras-Cartron, et al.. Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme. Molecular Cancer, BioMed Central, 2020, 19 (1), pp.1-36. ⟨10.1186/s12943-020-01155-z⟩. ⟨hal-02500622⟩
  • An-An Yin, Ya-Long He, Amandine Etcheverry, Yu-He Liu, Marc Aubry, et al.. Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas. Clinical Epigenetics, 2019, 11 (1), pp.76. ⟨10.1186/s13148-019-0670-9⟩. ⟨hal-02153239⟩
  • En-Ming Kang, An-An Yin, Ya-Long He, Wei-Jun Chen, Amandine Etcheverry, et al.. A five-CpG signature of microRNA methylation in non-G-CIMP glioblastoma. CNS Neuroscience and Therapeutics, Wiley, 2019, 25 (9), pp.937-950. ⟨10.1111/cns.13133⟩. ⟨hal-02121050⟩
  • Paul Peixoto, Amandine Etcheverry, Marc Aubry, Anaïs Missey, Camille Lachat, et al.. EMT is associated with an epigenetic signature of ECM remodeling genes. Cell Death and Disease, Nature Publishing Group, 2019, 10 (3), pp.205. ⟨10.1038/s41419-019-1397-4⟩. ⟨hal-02076497⟩
  • Paloma Compes, Emeline Tabouret, Amandine Etcheverry, Carole Colin, Romain Appay, et al.. Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016. Journal of Neuro-Oncology, Springer Verlag, 2019, 142 (3), pp.511-520. ⟨10.1007/s11060-019-03122-1⟩. ⟨hal-02076599⟩
  • An-An Yin, Nan Lu, Amandine Etcheverry, Marc Aubry, Jill Barnholtz-Sloan, et al.. A novel prognostic six-CpG signature in glioblastomas. CNS Neuroscience and Therapeutics, Wiley, 2018, 24 (3), pp.167-177. ⟨10.1111/cns.12786⟩. ⟨hal-01711026⟩
  • Stéphanie Lhomond, Tony Avril, Nicolas Dejeans, Konstantinos Voutetakis, Dimitrios Doultsinos, et al.. Dual IRE1 RNase functions dictate glioblastoma development. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (3), pp.e7929. ⟨10.15252/emmm.201707929⟩. ⟨hal-01777737⟩
  • Annabelle Monnier, Rachel Boniface, Régis Bouvet, Amandine Etcheverry, Marc Aubry, et al.. The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line. BMC Cancer, BioMed Central, 2018, 18 (1), pp.1213. ⟨10.1186/s12885-018-5094-y⟩. ⟨hal-01972440⟩
  • A. Yin, A. Etcheverry, Y. He, Marc Aubry, J. Barnholtz-Sloan, et al.. Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas. Oncotarget, Impact journals, 2017, 8 (52), pp.89607-89619. ⟨10.18632/oncotarget.19171⟩. ⟨hal-01647188⟩
  • Tony Avril, Amandine Etcheverry, Raphael Pineau, Joanna Obacz, Gwenaele Jegou, et al.. CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma. Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (23), pp.7360-7374. ⟨10.1158/1078-0432.CCR-17-1549⟩. ⟨hal-01671761⟩
  • Marc Aubry, Marie de Tayrac, Amandine Etcheverry, Anne Clavreul, Stéphan Saikali, et al.. From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget, Impact journals, 2015, 6 (14), pp.12094-12109. ⟨10.18632/oncotarget.3297⟩. ⟨hal-01396745⟩
  • Anne Clavreul, Amandine Etcheverry, Clément Tétaud, Audrey Rousseau, Tony Avril, et al.. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.. Journal of Neuro-Oncology, Springer Verlag, 2015, 122 (1), pp.1-10. ⟨10.1007/s11060-014-1683-z⟩. ⟨hal-01117114⟩
  • Amandine Etcheverry, Marc Aubry, Ahmed Idbaih, Elodie Vauleon, Yannick Marie, et al.. DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide. PLoS ONE, Public Library of Science, 2014, 9 (9), pp.e104455. ⟨10.1371/journal.pone.0104455⟩. ⟨hal-01358132⟩
  • Tony Avril, Elodie Vauléon, Abderrahmane Hamlat, Stéphan Saikali, Amandine Etcheverry, et al.. Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells.. Brain Pathology, Wiley, 2012, 22 (2), pp.159-74. ⟨10.1111/j.1750-3639.2011.00515.x⟩. ⟨inserm-00618443⟩
  • Elodie Vauleon, Avril Tony, Abderrahmane Hamlat, Amandine Etcheverry, Dan Cristian Chiforeanu, et al.. Immune genes are associated with human glioblastoma pathology and patient survival. BMC Medical Genomics, BioMed Central, 2012, 5 (1), pp.41. ⟨10.1186/1755-8794-5-41⟩. ⟨hal-01064487⟩
  • Anne Clavreul, Amandine Etcheverry, Agnès Chassevent, Véronique Quillien, Tony Avril, et al.. Isolation of a new cell population in the glioblastoma microenvironment.. Journal of Neuro-Oncology, Springer Verlag, 2012, 106 (3), pp.493-504. ⟨10.1007/s11060-011-0701-7⟩. ⟨inserm-00626532⟩
  • Véronique Quillien, Elodie Vauléon, Stephan Saikali, Thierry Lesimple, Abderrahmane Hamlat, et al.. Intérêt de la MGMT dans les gliomes. [MGMT analysis in gliomas].. Bulletin du Cancer, John Libbey Eurotext, 2011, 98 (3), pp.291-303. ⟨10.1684/bdc.2011.1332⟩. ⟨inserm-00587564⟩
  • Marie de Tayrac, Marc Aubry, Stephan Saïkali, Amandine Etcheverry, Cyrille Surbled, et al.. A 4-gene signature associated with clinical outcome in high-grade gliomas.. Clinical Cancer Research, American Association for Cancer Research, 2011, 17 (2), pp.317-27. ⟨10.1158/1078-0432.CCR-10-1126⟩. ⟨inserm-00545436⟩
  • Amandine Etcheverry, Marc Aubry, Marie de Tayrac, Elodie Vauleon, Rachel Boniface, et al.. DNA methylation in glioblastoma: impact on gene expression and clinical outcome.. BMC Genomics, BioMed Central, 2010, 11 (1), pp.701. ⟨10.1186/1471-2164-11-701⟩. ⟨inserm-00663706⟩
  • Lucie Karayan-Tapon, Véronique Quillien, Joëlle Guilhot, Michel Wager, Gaëlle Fromont, et al.. Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.. Journal of Neuro-Oncology, Springer Verlag, 2010, 97 (3), pp.311-22. ⟨10.1007/s11060-009-0031-1⟩. ⟨inserm-00435222⟩
  • Sylvie Jaillard, Séverine Drunat, Claude Bendavid, Azzedine Aboura, Amandine Etcheverry, et al.. Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series.. European Journal of Medical Genetics, Elsevier, 2010, 53 (2), pp.66-75. ⟨10.1016/j.ejmg.2009.10.002⟩. ⟨inserm-00434932⟩
  • Marie de Tayrac, Amandine Etcheverry, Marc Aubry, Stephan Saïkali, Abderrahmane Hamlat, et al.. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.. Genes, Chromosomes and Cancer, Wiley, 2009, 48 (1), pp.55-68. ⟨10.1002/gcc.20618⟩. ⟨inserm-00352960⟩

Conference papers3 documents

  • Marc Aubry, Marie de Tayrac, Stephan Saïkali, Amandine Etcheverry, Abderrahmane Hamlat, et al.. A Four-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas.. 9th Meeting of The European Association of NeuroOncology, Sep 2010, Maastricht, Netherlands. pp.iii5 O.16, ⟨10.1093/neuonc/noq085⟩. ⟨inserm-00550559⟩
  • Jean Mosser, Amandine Etcheverry, Stephan Saikali, Marc Aubry, Abderrahmane Hamlat, et al.. Integration of Genomic Alterations and Expression Profiling in Glioblastoma Multiforme.. 3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Apr 2009, Yokohama, Japan. pp.890 O59. ⟨inserm-00550564⟩
  • Marie de Tayrac, Marc Aubry, Stephan Saikali, Cyrille Surbled, Rachel Boniface, et al.. Gene Expression Meta-Analysis Identifies Grading and Survival Markers in Anaplastic Glioma.. 3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Apr 2009, Yokohama, Japan. pp.925 P47. ⟨inserm-00550572⟩

Patents1 document

  • Jean Mosser, Amandine Etcheverry, Marc Aubry, Jean-Yves Delattre. Biomarkers and methods for the prognosis of glioblastoma. United States, Patent n° : US20140011702 A1. 2014. ⟨hal-01117125⟩